Lv1
50 积分 2025-12-23 加入
POS0781 EFFICACY AND SAFETY OF ORAL DEUCRAVACITINIB IN PATIENTS WITH CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS: RESULTS FROM PAISLEY CLE, A GLOBAL, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL
22小时前
已关闭
The classification and diagnosis of cutaneous lupus erythematosus
2天前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
16天前
已完结
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
17天前
已完结
皖公网安备34019202002308
